Genetic analysis of fibrosarcoma of bone, a rare tumour entity closely related to osteosarcoma and malignant fibrous histiocytoma of bone

European Journal of Cell Biology

Volumn 83, Issue 9, 2004, Pages 483-491

  Hattinger, Claudia Maria ^a   Tarkkanen, Maija ^b,c   Benini, Stefania ^a   Pasello, Michela ^a   Stoico, Giuseppina ^a   Bacchini, Patrizia ^a   Knuutila, Sakari ^b   Scotlandi, Katia ^a   Picci, Piero ^a   Serra, Massimo ^a  

^a RIZZOLI ORTHOPAEDIC INSTITUTE   (Italy)

^b UNIVERSITY OF HELSINKI   (Finland)

^c HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

Author keywords

Chromosome 22; Comparative genomic hybridisation; Fibrosarcoma of bone; Immunohistochemistry; Microarray; Platelet derived growth factor beta; Real time quantitative PCR

Indexed keywords

DNA; PARAFFIN; PLATELET DERIVED GROWTH FACTOR B; PLATELET DERIVED GROWTH FACTOR RECEPTOR;

ADOLESCENT; ADULT; ANALYTIC METHOD; ARTICLE; AUTOCRINE EFFECT; BETA CHAIN; BONE DEMINERALIZATION; CHROMOSOME 22Q; CHROMOSOME ANALYSIS; CLINICAL ARTICLE; COMPARATIVE GENOMIC HYBRIDIZATION; CONTROLLED STUDY; CORRELATION ANALYSIS; DNA ISOLATION; DNA MICROARRAY; DNA SEQUENCE; FEMALE; FIBROSARCOMA; FREQUENCY ANALYSIS; GENE LOCATION; GENE NUMBER; GENETIC ANALYSIS; GENETIC DISORDER; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LUNG METASTASIS; MALE; MALIGNANT FIBROUS HISTIOCYTOMA; MOLECULAR GENETICS; OSTEOSARCOMA; PATHOGENESIS; PRIORITY JOURNAL; QUALITY CONTROL; REAL TIME POLYMERASE CHAIN REACTION; STRUCTURAL CHROMOSOME ABERRATION; TREATMENT PLANNING; TUMOR LOCALIZATION; TUMOR RECURRENCE;

EID: 7244254368     PISSN: 01719335     EISSN: None     Source Type: Journal    
DOI: 10.1078/0171-9335-00408     Document Type: Article

References (26)

1. Abdiu, A., Walz, T. M., Nishikawa, B. K., Wingren, S., Larsson, S. E., Wasteson, A., 1998. Human malignant fibrous histiocytomas in vitro: growth characteristics and their association with expression of mRNA for platelet-derived growth factor, transforming growth factor-alpha and their receptors. Eur. J. Cancer 34, 2094-2100.
2. Abdiu, A., Wingren, S., Larsson, S. E., Wasteson, A., Walz, T. M., 1999. Effects of human platelet-derived growth factor-AB on sarcoma growth in vitro and in vivo. Cancer Lett. 141, 39-45.
3. Benini, S., Baldini, N., Manara, M. C., Chano, T., Serra, M., Rizzi, S., Lollini, P. L., Picci, P, Scotlandi, K., 1999. Redundancy of autocrine loops in human osteosarcoma cells. Int. J. Cancer 80, 581-588.
4. Campanacci, M., 1999. Bone and soft tissue tumors. Springer-Verlag, Wien, pp. 149-159.
5. Capanna, R., Bertoni, F., Bacchini, P., Bacci, G., Guerra, A., Campanacci, M., 1984. Malignant fibrous histiocytoma of bone. The experience at the Rizzoli Institute: report of 90 cases. Cancer 54, 177-187.
6. Daigo, Y., Chin, S. F., Gorringe, K. L., Bobrow, L. G., Ponder, B. A., Pharoah, P. D., Caldas, C., 2001. Degenerate oligonucleotide primed-polymerase chain reaction-based array comparative genomic hybridization for extensive amplicon profiling of breast cancers: a new approach for the molecular analysis of paraffin-embedded cancer tissue. Am. J. Pathol. 158, 1623-1631.
7. Dorfman, H. D., Czerniak, B., 1995. Bone cancers. Cancer 75, 203-210.
8. El-Rifai, W., Larramendy, M. L., Bjorkqvist, A. M., Hemmer, S., Knuutila, S., 1997. Optimization of comparative genomic hybridization using fluorochrome conjugated to dCTP and dUTP nucleotides. Lab. Invest. 77, 699-700.
9. Hattinger, C. M., Reverter-Branchat, G., Remondini, D., Castellani, G. C., Benini, S., Pasello, M., Manara, M. C., Scotlandi, K., Picci, P., Serra, M., 2003. Genomic imbalances associated with methotrexate resistance in human osteosarcoma cell lines detected by comparative genomic hybridization-based techniques. Eur. J. Cell Biol. 82, 483-493.
10. Jin, H. M., Robinson, D. F., Liang, Y., Fahl, W. E., 1994. SIS/PDGF-B promoter isolation and characterization of regulatory elements necessary for basal expression of the SIS/PDGF-B gene in U2-OS osteosarcoma cells. J. Biol. Chem. 269, 28648-28654.
11. Kahn, L. B., Vigorita, V., 2002. Fibrosarcoma of bone, in: Fletcher, C. D.M., Unni, K. (Eds.), World Health Organization Classification of Tumours. Pathology and Genetics of Tumours of Soft Tissue and Bone. IARC Press, Lyon, pp. 289-290.
12. Knuutila, S., Bjorkqvist, A. M., Autio, K., Tarkkanen, M., Wolf, M., Monni, O., Szymanska, J., Larramendy, M. L., Tapper, J., Pere, H., El-Rifai, W., Hemmer, S., Wasenius, V. M., Vidgren, V., Zhu, Y., 1998. DNA copy number amplifications in human neoplasms: review of comparative genomic hybridization studies. Am. J. Pathol. 152, 1107-1123.
13. Mao, X., Lillington, D., Child, F., Russel-Jones, R., Young, B., Whittaker, S., 2002. Comparative genomic hybridization analysis of primary cutaneous B-cell lymphomas: Identification of common genomic alterations in disease pathogenesis. Genes Chromosomes Cancer 35, 144-155.
14. McGary, E. C., Weber, K., Mills, L., Doucet, M., Lewis, V., Lev, D. C., Fidler, I. J., Bar-Eli, M., 2002. Inhibition of platelet-derived growth factor-mediated proliferation of osteosarcoma cells by the novel tyrosine kinase inhibitor STI571. Clin. Cancer Res. 8, 3584-3591.
15. Papagelopoulos, P. J., Galanis, E. C., Trantafyllidis, P., Boscainos, P. J., Sim, F. H., Unni, K. K., 2002. Clinicopathologic features, diagnosis, and treatment of fibrosarcoma of bone. Am. J. Orthop. 31, 253-257.
16. Serra, M., Scotlandi, K., Sollazzo, M. R., Sarti, M., Maurici, D., Benini, S., Picci, P., Bertoni, F., Baldini, N., 1996. Value of immunohistochemical detection of noncollagenous proteins of bone for the diagnosis of bone tumours. Int. J. Oncol. 9, 257-261.
17. Sheng, W. Q., Hashimoto, H., Okamoto, S., Ishida, T., Meis-Kindblom, J. M., Kindblom, L. G., Hisaoka, M., 2001. Expression of COL1A1-PDGFB fusion transcripts in superficial adult fibrosarcoma suggests a close relationship to dermatofibrosarcoma protuberans. J. Pathol. 194, 88-94.
18. Simon, M. P., Pedeutour, F., Sirvent, N., Grosgeorge, J., Minoletti, F., Coindre, J. M., Terrier-Lacombe, M. J., Mandahl, N., Craver, R. D., Blin, N., Sozzi, G., Turc-Carel, C., O'Brien, K. P., Kedra, D., Fransson, I., Guilbaud, C., Dumanski, J. P., 1997. Deregulation of the platelet-derived growth factor B-chain gene via fusion with collagen gene COL1A1 in dermatofibrosarcoma protuberans and giant-cell fibroblastoma. Nat. Genet. 15, 95-98.
19. Smits, A., Funa, K., Vassbotn, F. S., Beausang-Linder, M., af Ekenstam, F., Heldin, C. H., Westermark, B., Nister, M., 1992. Expression of platelet-derived growth factor and its receptors in proliferative disorders of fibroblastic origin. Am. J. Pathol. 140, 639-648.
20. Sulzbacher, I., Traxler, M., Mosberger, I., Lang, S., Chott, A., 2000. Platelet-derived growth factor-AA and -alpha receptor expression suggests an autocrine and/or paracrine loop in osteosarcoma. Mod. Pathol. 13, 632-637.
21. Sulzbacher, I., Birner, P., Trieb, K., Traxler, M., Lang, S., Chott, A., 2003. Expression of platelet-derived growth factor-AA is associated with tumor progression in osteosarcoma. Mod. Pathol. 16, 66-71.
22. Taconis, W. K., Mulder, J. D., 1984. Fibrosarcoma and malignant fibrous histiocytoma of long bones: radiographic features and grading. Skeletal Radiol. 11, 237-245.
23. Taniuchi, K., Yamada, Y., Nonomura, A., Takehara, K., 1997. Immunohistochemical analysis of platelet-derived growth factor and its receptors in fibrohistiocytic tumors. J. Cutan. Pathol. 24, 393-397.
24. Tarkkanen, M., Karhu, R., Kallionemi, A., Elomaa, I., Kivioja, A. H., Nevalainen, J., Böhling, T., Karaharju, E., Hyytinen, E., Knuutila, S., Kallionemi, O.-P., 1995. Gains and losses of DNA sequences in osteosarcoma by comparative genomic hybridization. Cancer Res. 55, 1334-1338.
25. Tarkkanen, M., Elomaa, I., Blomqvist, C., Kivioja, A. H., Kellokumpu-Lehtinen, P., Bohling, T., Valle, J., Knuutila, S., 1999. DNA sequence copy number increase at 8q: a potential new prognostic marker in high-grade osteosarcoma. Int. J. Cancer 84, 114-121.
26. Uren, A., Merchant, M. S., Sun, C. J., Vitolo, M. I., Sun, Y., Tsokos, M., Illei, P. B., Ladanyi, M., Passaniti, A., Mackall, C., Toretsky, J. A., 2003. Beta-platelet-derived growth factor receptor mediates motility and growth of Ewing's sarcoma cells. Oncogene 22, 2334-2342.